Embecta (EMBC) Operating Margin (2020 - 2026)
Embecta's (EMBC) quarterly Operating Margin came in at 15.78% in Q1 2026, down 851.0% year-on-year from 2.1% in Q1 2025, and down 50.52% quarter-over-quarter from 31.89% in Q4 2025.
Embecta (EMBC) Operating Margin (2020 - 2026) Analysis & Trends
Embecta has disclosed Operating Margin across 7 years of filings, most recently posting 15.78% for Q1 2026.
- Operating Margin for Q1 2026 came in at 15.78%, down 851.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 25.78% (up 969.0% YoY), and the FY2025 annual result was 22.41%, up 756.0% from the prior year.
- Operating Margin came in at 15.78% for Q1 2026 at Embecta, down from 31.89% in the prior quarter.
- In the past five years, Operating Margin ranged from a high of 36.03% in Q1 2022 to a low of 1.09% in Q3 2022.
- The 5-year median for Operating Margin is 20.06% (2023), against an average of 20.21%.
- Across the five-year window, Operating Margin sank 4006 bps in 2022 and surged 2093 bps in 2025, its largest moves.
- Embecta's Operating Margin stood at 32.21% in 2022, then slumped by 49 bps to 16.41% in 2023, then slumped by 33 bps to 10.96% in 2024, then jumped by 191 bps to 31.89% in 2025, then slumped by 51 bps to 15.78% in 2026.
- The last three Operating Margin figures came in at 15.78% (Q1 2026), 31.89% (Q4 2025), and 21.4% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 30.87% |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | 1.97% |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | 5.74% |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 34.92% |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 20.96% |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | 4.04% |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | -2.87% |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 13.65% |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | 2.44% |
| 10 | Embecta | 183.23 Mn | -10.17 Mn | 127.80 Mn | 15.78% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 15.78% |
| Dec 31, 2025 | 31.89% |
| Sep 30, 2025 | 21.40% |
| Jun 30, 2025 | 31.81% |
| Mar 31, 2025 | 24.29% |
| Dec 31, 2024 | 10.96% |
| Sep 30, 2024 | 9.16% |
| Jun 30, 2024 | 20.51% |
| Mar 31, 2024 | 13.65% |
| Dec 31, 2023 | 16.41% |
| Sep 30, 2023 | 9.15% |
| Jun 30, 2023 | 17.93% |
| Mar 31, 2023 | 20.06% |
| Dec 31, 2022 | 32.21% |
| Sep 30, 2022 | -1.09% |
| Jun 30, 2022 | 33.36% |
| Mar 31, 2022 | 36.03% |
| Dec 31, 2021 | 40.30% |
| Sep 30, 2021 | 38.96% |
| Jun 30, 2021 | 42.14% |